Asthma: Specific preventive strategies

Postgraduate Medicine

Volumn 100, Issue 2, 1996, Pages 105-120

  Morris, Richard J ^a,b  

^a PARK NICOLLET CLINIC   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FENOTEROL; FLUNISOLIDE; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLPREDNISOLONE; NEDOCROMIL SODIUM; PIRBUTEROL ACETATE; PREDNISONE; SALBUTAMOL; SALMETEROL XINAFOATE; THEOPHYLLINE; TRIAMCINOLONE ACETONIDE; ZAFIRLUKAST; ZILEUTON;

AEROSOL; ALLERGY; ASTHMA; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; INHALATIONAL DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; PEAK EXPIRATORY FLOW; TREATMENT PLANNING;

ANTI-ASTHMATIC AGENTS; ASTHMA; HUMANS;

EID: 9444284953     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.1996.08.53     Document Type: Article

References (21)

1. Weiss KB, Gap PJ, Wapner DK. Breathing better or wheezing worse? The changing epidemiology of asthma morbidity and morality. Annu Rev Public Health 1993; 14: 491 – 513
2. National Asthma Education Program &pert Pand. Guidelines for the diagnosis and management of asthma. Bethesda: US Dept of Health and Human Services, 1991 Aug; NIH publication No. 91–3042
3. Kalliel JN, Goldstein BM, Braman SS, et al. High frequency of atopic asthma in a pulmonary clinic population. Chest 1989; 96 (6): 1336 – 40
4. Burrows B, Martinez FD, Halonen M, et al. Association of asthma with serum IgE levels and skin-test reactivity to allergens. N Eng! J Med 1989; 320 (5): 271 – 7
5. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years of life. N Engl J Med 1995; 332 (3): 133 – 8
6. Lemanske RF Jr. Inflammation's role in mild and moderate asthma. J Respir Dis 1992; 13 (10): S9 – 14
7. Reed CE. Pathogenesis of asthma. Airway Diseases 1985 Dec; 10 – 6
8. Beasley R, Roche WR, Roberts JA, et al. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139 (3): 806 – 17
9. Roche WR, Beasley R, Williams JH, et al. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989; 1 (8637): 520 – 4
10. Bukantz SC. Acute severe asthma: the late-phase reaction and the continuing challenge. (Editorial) Hosp Pract (Off Ed) 1986; 21 (11): 10 – 6
11. Sean MR, Taylor DR, Print CG, et al. Regular inhaled beta-agonist treatment in bronchial asthma. Lancet 1990; 336 (8728): 1391 – 6
12. Spitzer WO, Suissa S, Ernst P, et al. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med 1992; 326 (8): 501 – 6
13. McFadden ER Jr. The beta2-agonist controversy revisited. Ann Allergy Asthma Immunol 1995; 75 (2): 173 – 6
14. Mullen M, Mullen B, Carey M. The association between beta-agonist use and death from asthma: a meta-analytic integration of case-control studies. JAMA 1993; 270 (15): 1842 – 5
15. Cockcroft DW, McParland CP, Britto SA, et al. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 1993; 342 (8875): 833 – 7
16. Cockcroft DW. Beta-agonists, airway hyperresponsiveness, and asthma. (Editorial) J Allergy Clin Immunol 1992; 90 (5): 739 – 41
17. D'Alonzo GE, Nathan RA, Henochowicz: S, et al. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. JAMA 1994; 271 (18): 1412 – 6
18. Toogood JH. What are the clinically relevant risks, and what ro do? Making better—and safer—use of inhaled steroids. J Respir Dis 1993; 14 (2): 221 – 7
19. Reed CE. Aerosol glucocorticoid treatment of asthma: adults. Am Rev Respir Dis 1990; 141 (2 Pt 2): S82 – 8
20. Larsen JS, Hahn M, Kochevar JW, et al. Administration errors with a conventional metered dose inhaler versus a novel breath actuated device. Ann Allergy 1993; 71 (2): 103 – 6
21. The role of the allergist in cost-effective treatment of asthma. Arlington Heights, Ill: American College of Allergy, Asthma & Immunology, 1995 May: 1 – 11